Wen-Zhao Zhong
Thoracic surgeon-scientist and hospital Vice President who led the ADJUVANT/CTONG1104 trial establishing adjuvant EGFR-TKI therapy in resected lung cancer.
Overview
Wen-Zhao Zhong is Vice President of Guangdong Provincial People's Hospital and a thoracic surgical oncologist at the Guangdong Lung Cancer Institute. He was first author of the ADJUVANT/CTONG1104 phase 3 trial, which compared adjuvant gefitinib with chemotherapy in resected EGFR-mutant non-small-cell lung cancer, and has published extensively on perioperative targeted therapy through the Chinese Thoracic Oncology Group.
Pages like this
not linked directly; found by shared links- PersonNu Zhang
Shares Guangdong Provincial People's Hospital and the tag leadership.
- PersonHidetoshi Hayashi
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
- PersonMartin Schuler
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
- PersonCaicun Zhou
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
- PersonKaren Kelly
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
- PersonMatthias Guckenberger
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
- PersonJin Seok Ahn
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
- PersonTony S. K. Mok
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.